ATLAS / Macro Radar / Reporting / BOLT

Bolt Biotherapeutics, Inc. (BOLT) reporting calendar

Bolt Biotherapeutics, Inc. files periodic reports with the SEC as BOLT on Nasdaq. Atlas tracks 22 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
23 Jul 2026 – 1 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
12 May 2026
Reports on record
22

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202612 May 202642 days0001193125-26-219382
10-K31 Dec 202512 Mar 202671 days0001193125-26-104121
10-Q30 Sep 202512 Nov 202543 days0001193125-25-277549
10-Q30 Jun 202514 Aug 202545 days0001641281-25-000007
10-Q31 Mar 202512 May 202542 days0000950170-25-069188
10-K31 Dec 202424 Mar 202583 days0000950170-25-043873
10-Q30 Sep 202412 Nov 202443 days0000950170-24-125413
10-Q30 Jun 202413 Aug 202444 days0000950170-24-096200
10-Q31 Mar 202414 May 202444 days0000950170-24-059564
10-K31 Dec 202321 Mar 202481 days0000950170-24-034692
10-Q30 Sep 20239 Nov 202340 days0000950170-23-062048
10-Q30 Jun 20237 Aug 202338 days0000950170-23-039061
10-Q31 Mar 202311 May 202341 days0000950170-23-021233
10-K31 Dec 202229 Mar 202388 days0000950170-23-010613
10-Q30 Sep 202210 Nov 202241 days0000950170-22-024487
10-Q30 Jun 202210 Aug 202241 days0000950170-22-016460
10-Q31 Mar 202212 May 202242 days0000950170-22-009664
10-K31 Dec 202130 Mar 202289 days0000950170-22-005047
10-Q30 Sep 20219 Nov 202140 days0001564590-21-055774
10-Q30 Jun 202112 Aug 202143 days0001564590-21-044002
10-Q31 Mar 202113 May 202143 days0001564590-21-027545
10-K31 Dec 202031 Mar 202190 days0001193125-21-102253

Source: SEC EDGAR company submissions for CIK 0001641281. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.